STAT5A and acute myeloid leukemia: We have also very recently revealed that Pim kinases are involved downstream of STAT5 in enhancing mTORC1/MCL-1 pathway in FLT3-ITD-expressing AML cells to confer these cells resistance to PI3K/Akt inhibitors [39].